加速度计睡眠指标与终生精神疾病诊断的关联:UK Biobank 89,205 人横断面研究
该研究基于 UK Biobank 89,205 名参与者的 7 天腕戴加速度计数据,提取 10 项睡眠指标,分析其与终生住院精神疾病诊断及多基因风险评分的关联。结果显示睡眠模式差异是多种精神疾病的跨诊断特征,睡眠质量指标受影响通常比睡眠时长更明显,但效应量普遍较小。
要点
- 睡眠模式差异是多种精神疾病的跨诊断特征,应不受诊断限制地予以考虑。
- 加速度计可规模化客观测量睡眠,适用于精神科临床研究与实践中数万人规模。
- 睡眠质量指标(如睡眠效率)受影响通常比单纯睡眠时长更明显。
核心结论
- 睡眠模式差异是终生精神疾病患者的跨诊断特征,应不受诊断限制地予以考虑。
- 加速度计提供了可规模化客观测量睡眠性质的方式,适用于精神科临床研究与实践中数万人规模。
研究设计与样本
- 基于 UK Biobank 队列的事后横断面分析,纳入 89,205 名参与者(年龄 43 至 79 岁,56% 女性,97% 自报白人)。
- 从 2013 至 2015 年的 7 天加速度计记录中提取 10 项可解释睡眠指标:就寝时间、起床时间、睡眠时长、入睡后觉醒、睡眠效率、觉醒次数、最长连续睡眠时长、小睡次数、就寝时间变异性、睡眠时长变异性。
- 分析上述指标与加速度计记录日期之前任何时间的终生住院诊断(重性抑郁障碍、焦虑障碍、双相障碍/躁狂、精神分裂症谱系障碍)及多基因风险评分的关联。
- 协变量包括加速度计记录时的年龄与季节、性别、Townsend 剥夺指数(社会经济地位指标)及前 10 个基因型主成分。
主要发现
- 每种诊断与 10 项加速度计睡眠指标的中位数 8.5 项相关。
- 睡眠质量指标(如睡眠效率)通常比单纯睡眠时长受影响更明显。
- 效应量普遍较小:4 种诊断中最大效应量为终生住院重性抑郁障碍诊断与睡眠效率的关联,β = -0.11(95%CI -0.13 至 -0.10,p = 3 × 10-56,FDR = 6 × 10-55)。
- 关联在不同祖先背景和性别间大体可重复,加速度计指标与自报睡眠性质一致。
临床怎么用
- 在精神科临床研究与实践中,可考虑使用加速度计客观、规模化地测量睡眠性质。
- 对精神疾病患者应关注睡眠模式差异,而不限于特定诊断。
局限性
- 使用基于加速度计的睡眠测量。
- 精神疾病诊断与加速度计测量之间存在时间间隔。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Sleep problems are both symptoms of and modifiable risk factors for many psychiatric disorders. Wrist-worn accelerometers enable objective measurement of sleep at scale. Here, we aimed to examine the association of accelerometer-derived sleep measures with psychiatric diagnoses and polygenic risk scores in a large community-based cohort. METHODS AND FINDINGS: In this post hoc cross-sectional analysis of the UK Biobank cohort, 10 interpretable sleep measures-bedtime, wake-up time, sleep duration, wake after sleep onset, sleep efficiency, number of awakenings, duration of longest sleep bout, number of naps, and variability in bedtime and sleep duration-were derived from 7-day accelerometry recordings across 89,205 participants (aged 43 to 79, 56% female, 97% self-reported white) taken between 2013 and 2015. These measures were examined for association with lifetime inpatient diagnoses of major depressive disorder, anxiety disorders, bipolar disorder/mania, and schizophrenia spectrum disorders from any time before the date of accelerometry, as well as polygenic risk scores for major depression, bipolar disorder, and schizophrenia. Covariates consisted of age and season at the time of the accelerometry recording, sex, Townsend deprivation index (an indicator of socioeconomic status), and the top 10 genotype principal components. We found that sleep pattern differences were ubiquitous across diagnoses: each diagnosis was associated with a median of 8.5 of the 10 accelerometer-derived sleep measures, with measures of sleep quality (for instance, sleep efficiency) generally more affected than mere sleep duration. Effect sizes were generally small: for instance, the largest magnitude effect size across the 4 diagnoses was β = -0.11 (95% confidence interval -0.13 to -0.10, p = 3 × 10-56, FDR = 6 × 10-55) for the association between lifetime inpatient major depressive disorder diagnosis and sleep efficiency. Associations largely replicated across ancestries and sexes, and accelerometry-derived measures were concordant with self-reported sleep properties. Limitations include the use of accelerometer-based sleep measurement and the time lag between psychiatric diagnoses and accelerometry. CONCLUSIONS: In this study, we observed that sleep pattern differences are a transdiagnostic feature of individuals with lifetime mental illness, suggesting that they should be considered regardless of diagnosis. Accelerometry provides a scalable way to objectively measure sleep properties in psychiatric clinical research and practice, even across tens of thousands of individuals.
引用
- Wainberg M, Jones SE, Beaupre LM, et al. Association of accelerometer-derived sleep measures with lifetime psychiatric diagnoses: A cross-sectional study of 89,205 participants from the UK Biobank. PLoS Med. 2021. PMID: 34637446. doi:10.1371/journal.pmed.1003782
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。